3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
2
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
235
Neoplasms
207
Carcinoma, Non-Small-Cell Lung
101
Colorectal Neoplasms
99
Prostatic Neoplasms
93
Lung Neoplasms
78
Multiple Myeloma
53
Melanoma
52
Pancreatic Neoplasms
50
Head and Neck Neoplasms
50
Neoplasm Metastasis
48
Leukemia, Myeloid, Acute
44
Carcinoma, Hepatocellular
43
Ovarian Neoplasms
39
Brain Neoplasms
39
Squamous Cell Carcinoma of Head and Neck
37
Recurrence
37
Glioblastoma
33
Uterine Cervical Neoplasms
32
Glioma
31
Sarcoma
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Stomach Neoplasms
28
Lymphoma, Non-Hodgkin
28
Lymphoma
27
Colonic Neoplasms
27
Carcinoma, Renal Cell
26
Lymphoma, Follicular
25
Esophageal Neoplasms
24
Rectal Neoplasms
23
Interventions
Raltegravir Potassium
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hepatic Insufficiency
×
90 days
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled